Protonotariou Efthymia, Mantzana Paraskevi, Meletis Georgios, Tychala Areti, Kassomenaki Angeliki, Vasilaki Olga, Kagkalou Georgia, Gkeka Ioanna, Archonti Maria, Kati Styliani, Metallidis Simeon, Skoura Lemonia
Department of Microbiology, AHEPA University Hospital, Thessaloniki 54636, Greece.
Medical School, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece.
FEMS Microbes. 2021 Dec 2;2:xtab021. doi: 10.1093/femsmc/xtab021. eCollection 2021.
Northern Greece was struck by an intense second COVID-19 (coronavirus disease 2019) epidemic wave during the fall of 2020. Because of the coinciding silent epidemic of multidrug-resistant organisms, the handling of COVID-19 patients became even more challenging. In the present study, the microbiological characteristics of bacteremias in confirmed cases of hospitalized COVID-19 patients were determined. Data from 1165 patients hospitalized between September and December 2020 were reviewed regarding the frequency of bloodstream infections, the epidemiology and the antibiotic susceptibility profiles of the causative bacteria. The hospital's antibiotic susceptibility data for all major nosocomial pathogens isolated from bacteremias of COVID-19 patients between September and December 2020 versus those between September and December 2019 were also compared. Overall, 122 patients developed bacteremia (10.47%). The average of time interval between hospitalization date and development of bacteremia was 13.98 days. Admission to ICU occurred in 98 out of 122 patients with an average stay time of 15.85 days and 90.81% in-hospital mortality. In total, 166 pathogens were recovered including 114 Gram-negative bacteria and 52 Gram-positive cocci. was the most frequent ( = 51) followed by ( = 45) and ( = 31). Bacteremias in hospitalized COVID-19 patients were related with prolonged time of hospitalization and higher in-hospital mortality, and the isolated microorganisms represented the bacterial species that were present in our hospital before the COVID-19 pandemic. Worryingly, the antibiotic resistance rates were increased compared with the pre-pandemic era for all major opportunistic bacterial pathogens. The pandemic highlighted the need for continuous surveillance of patients with prolonged hospitalization.
2020年秋季,希腊北部遭受了第二波严重的新冠疫情(2019冠状病毒病)冲击。由于多重耐药菌的无声流行同时出现,新冠患者的救治变得更具挑战性。在本研究中,我们确定了住院新冠确诊患者菌血症的微生物学特征。回顾了2020年9月至12月期间住院的1165例患者的血流感染频率、致病菌的流行病学及抗生素敏感性谱数据。还比较了该医院2020年9月至12月与2019年9月至12月从新冠患者菌血症中分离出的所有主要医院病原体的抗生素敏感性数据。总体而言,122例患者发生了菌血症(10.47%)。住院日期与菌血症发生之间的平均时间间隔为13.98天。122例患者中有98例入住了重症监护病房,平均住院时间为15.85天,院内死亡率为90.81%。共分离出166株病原体,包括114株革兰阴性菌和52株革兰阳性球菌。大肠埃希菌最为常见(n = 51),其次是肺炎克雷伯菌(n = 45)和鲍曼不动杆菌(n = 31)。住院新冠患者的菌血症与住院时间延长和较高的院内死亡率相关,分离出的微生物代表了新冠疫情大流行之前我院就已存在的细菌种类。令人担忧的是,与疫情前相比,所有主要机会性细菌病原体的抗生素耐药率均有所上升。这场大流行凸显了对长期住院患者进行持续监测的必要性。